Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016-17
Abstract
Objective: To determine the relative risk of death following exposure to treatments for OUD compared to no treatment.
Methods: In this retrospective cohort study we compiled and merged state agency data on accidental and undetermined opioid overdose...
Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality
Abstract
Background: A cascade of care (CoC) model may improve understanding of gaps in addiction treatment availability and quality over current single measure methods. Despite increased funding, opioid overdose rates remain high. Therefore, it is critical to...
Today, we are not here to dwell solely on the problem. Instead, I want to share a vision for an innovative, comprehensive, and consilient system of opioid addiction management that can turn the tide in this epidemic of overdose deaths. This approach involves the creation of Centers for Addiction and Mental Health to integrate treatment, research, judicial oversight, and social...
Semaglutide Shows Promise in Treating Alcohol Use Disorder, New Study Finds
A groundbreaking Phase 2 clinical trial published in JAMA Psychiatry has revealed that semaglutide—a medication already widely prescribed for type 2 diabetes and obesity—may offer a promising new treatment pathway for individuals with alcohol use disorder (AUD).
📉 What Did the Study Find?
Researchers from the...
Tennessee Department of Health (TDH) Harm Reduction ECHO
Addiction medicine professionals across Tennessee are increasingly being called to the frontlines of overlapping public health crises—opioid overdose, hepatitis C, and rising rates of substance use disorders. As the complexity of care continues to grow, so too does the need for collaborative, evidence-informed solutions that...
Reflections from the Rockies: TNSAM at the 56th Annual ASAM Conference
April 24–27, 2025 | Gaylord Rockies Resort, Aurora, Colorado
The crisp mountain air of Colorado wasn’t the only thing that invigorated attendees at the 56th Annual ASAM Conference this year. Held at the stunning Gaylord Rockies Resort, this year’s conference marked a turning point—not just in location, but in...
The Tennessee Society of Addiction Medicine (TNSAM) is pleased to inform its members about an exciting research opportunity through Vanderbilt University Medical Center’s The Vanderbilt Oregon Collaborative Scholar Training in Addiction Medicine (COSTAR) program, an NIH-funded initiative designed to advance research and training in addiction medicine. This research program, housed...
Reflecting on the Success of the 55th Annual ASAM Conference
The 55th Annual ASAM Conference, held at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, was a resounding success. Under the theme “Innovations in Addiction Medicine and Science,” this year’s event showcased a range of breakthroughs and ongoing developments in the field of addiction...